Raising CPR survival rates

Posted on: Monday, January 14th, 2019

In a UK survey of 8,000 heart-attack resuscitations, only 2.8% of patients were still alive 30 days later due to low blood flow to the arteries and brain. The HemaShock device from Israel’s Oneg Hakarmel (developer of HemaClear – see here) takes blood from the limbs to maintain essential organs.